The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
November 20th 2024
Bimekizumab-bkzx is the first and only approved medication that targets both interleukin (IL) 17F and IL-17A.
November 13th 2024
FDA Approves New Treatment for NSCLC in Patients with Certain EGFR Mutations
July 12th 2013The FDA today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.
Read More
FDA Publishes Draft Guidance on Gene and Cell Therapy Clinical Trials
July 9th 2013Many of the types of drugs addressed by the guidance document could be categorized as specialty drugs because they require special handling, frequent dosing adjustments, and intensive clinical monitoring of adverse effects.
Read More
Pharmacy-Based Clinical Trial Recruitment: A Potential New Role for the Pharmacist?
July 2nd 2013Research presented on June 25, 2013, at the Drug Information Association (DIA) 2013 49th Annual Meeting could trigger a paradigm shift in clinical trial patient recruitment and could change the way pharmacists engage with patients as new drugs make their way through the FDA approval process.
Read More
Diplomat Specialty Pharmacy Receives Compounding Pharmacy Accreditation from PCAB
June 27th 2013Diplomat Specialty Pharmacy, the country's largest independent specialty pharmacy servicing the needs of patients and physicians nationwide, is pleased to announce the company's compounding pharmacy has been accredited by the Pharmacy Compounding Accreditation Board (PCAB).
Read More
Avella Specialty Pharmacy: Overcoming Oncology Adherence Barriers
June 18th 2013Specialty Pharmacy Times sat down to talk with Dr. Eric Sredzinski about the controversial topic of pricing for oncology medications, as well as common patient reimbursement hurdles and Avella's technologically savvy efforts to break down patient adherence barriers.
Read More
DIA Spotlights Hot Topics in Drug Development and Regulation
June 17th 2013Patient engagement, financial backing, and personalized medicine-3 of the most pressing issues in drug development and regulatory affairs-will be discussed at length at the DIA 2013 49th Annual Meeting, June 23-27 in Boston.
Read More
Site-of-Care Optimization Under the Medical Benefit
June 15th 2013Michael Einodshofer, director, utilization management, Walgreens, describes how contractual methodologies and cost differences across various sites of service can influence how a specialty drug is reimbursed under the medical benefit.
Watch
FDA Approves Xgeva for Adults with Giant Cell Tumor of Bone
June 13th 2013The FDA today approved denosumab (Xgeva injection, for subcutaneous use) for the treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.
Read More
Aetna and Cardinal Health Specialty Solutions Alliance to Share Best Practices at AHIP
June 12th 2013At the Association for Health Insurance Plan's (AHIP) conference this Thursday, medical directors from Cardinal Health Specialty Solutions and Aetna will provide expert insight into how collaboration between payers and physicians can directly lead to better cancer care that is more effective and costs less.
Read More